ROTHERMEL ROBERT B 4
4 · Adamis Pharmaceuticals Corp · Filed Jul 11, 2018
Insider Transaction Report
Form 4
ROTHERMEL ROBERT B
Director
Transactions
- Award
Stock Option (Right to buy)
2018-07-09+30,000→ 30,000 totalExercise: $4.28Exp: 2028-07-09→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The option vests monthly over a period of twelve months commencing on the grant date. The option is granted pursuant to the Company's 2009 Equity Incentive Plan and is subject to other provisions as are set forth in the option agreement relating to such grant under the plan.